NCT05637216View on ClinicalTrials.gov

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 17, 2023

Primary Completion Date

August 17, 2027

Study Completion Date

August 17, 2027

Conditions
Radiation Induced Fibrosis
Interventions
DRUG

Losartan 25 milligram capsule

Losartan 25 milligram oral capsule

DRUG

Placebo

Placebo 25 milligram oral capsule

Trial Locations (1)

81632

RECRUITING

Vail Health Shaw Cancer Center, Edwards

All Listed Sponsors
collaborator

Steadman Philippon Research Institute

OTHER

lead

Shaw Cancer Center

OTHER